Johanna M. M. Gijtenbeek

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

Medicine, Oncology, Radiation Oncology +17

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent et al. · The Lancet Oncology · 2016 · 498 citations · Full text

Medicine, Oncology, Pharmacology +16

<i>IDH1</i> mutations in low-grade astrocytomas predict survival but not response to temozolomide

Hendrikus J. Dubbink, Walter Taal, Ronald van Marion et al. · Neurology · 2009 · 187 citations

Medicine, Oncology, Radiation Oncology +14

Westeinde Sciatica Trial: randomized controlled study of bed rest and physiotherapy for acute sciatica

Derk J. Hofstee, Johanna M. M. Gijtenbeek, P.H. Hoogland et al. · Journal of Neurosurgery Spine · 2002 · 113 citations

Medicine, Physical Medicine, Rehabilitation Medicine +17

Primary central nervous system T-cell lymphoma

Johanna M. M. Gijtenbeek, Marc K. Rosenblum, Lisa M. DeAngelis · Neurology · 2001 · 67 citations · Full text

Medicine, Neurology, Oncology +13